Serina Therapeutics Statistics

Total Valuation

SER has a market cap or net worth of $22.78 million. The enterprise value is $22.56 million.

Market Cap	22.78M
Enterprise Value	22.56M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, after market close.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

SER has 12.31 million shares outstanding. The number of shares has increased by 38.47% in one year.

Current Share Class	12.31M
Shares Outstanding	12.31M
Shares Change (YoY)	+38.47%
Shares Change (QoQ)	+3.14%
Owned by Insiders (%)	11.05%
Owned by Institutions (%)	3.51%
Float	6.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	171.45
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	173.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.71

Current Ratio	1.71
Quick Ratio	0.86
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-112.78

Financial Efficiency

Return on equity (ROE) is -8,159.24% and return on invested capital (ROIC) is -739.23%.

Return on Equity (ROE)	-8,159.24%
Return on Assets (ROA)	-219.58%
Return on Invested Capital (ROIC)	-739.23%
Return on Capital Employed (ROCE)	-709.03%
Weighted Average Cost of Capital (WACC)	4.82%
Revenue Per Employee	$10,000
Profits Per Employee	-$1.50M
Employee Count	13
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

In the past 12 months, SER has paid $18,000 in taxes.

Income Tax	18,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.38% in the last 52 weeks. The beta is 0.10, so SER's price volatility has been lower than the market average.

Beta (5Y)	0.10
52-Week Price Change	-68.38%
50-Day Moving Average	1.92
200-Day Moving Average	3.63
Relative Strength Index (RSI)	44.82
Average Volume (20 Days)	200,251

Short Selling Information

The latest short interest is 373,657, so 3.03% of the outstanding shares have been sold short.

Short Interest	373,657
Short Previous Month	110,517
Short % of Shares Out	3.03%
Short % of Float	5.51%
Short Ratio (days to cover)	0.04

Income Statement

In the last 12 months, SER had revenue of $130,000 and -$19.44 million in losses. Loss per share was -$1.91.

Revenue	130,000
Gross Profit	-13.03M
Operating Income	-24.02M
Pretax Income	-19.20M
Net Income	-19.44M
EBITDA	-23.95M
EBIT	-24.02M
Loss Per Share	-$1.91

Full Income Statement

Balance Sheet

The company has $3.06 million in cash and $3.32 million in debt, giving a net cash position of -$267,000 or -$0.02 per share.

Cash & Cash Equivalents	3.06M
Total Debt	3.32M
Net Cash	-267,000
Net Cash Per Share	-$0.02
Equity (Book Value)	-37,000
Book Value Per Share	-0.46
Working Capital	2.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.96 million and capital expenditures -$59,000, giving a free cash flow of -$18.01 million.

Operating Cash Flow	-17.96M
Capital Expenditures	-59,000
Depreciation & Amortization	73,000
Net Borrowing	4.91M
Free Cash Flow	-18.01M
FCF Per Share	-$1.46

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-18,478.46%
Pretax Margin	-14,766.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SER does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.47%
Shareholder Yield	-38.47%
Earnings Yield	-87.20%
FCF Yield	-80.82%

Analyst Forecast

The average price target for SER is $15.00, which is 710.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	710.81%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	95.53%
EPS Growth Forecast (5Y)	-9.10%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SER has an Altman Z-Score of -19.46 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-19.46
Piotroski F-Score	3